Seroprevalence of Acanthamoeba Antibodies in Rheumatoid Arthritis Patients by IFAT, Tehran, Iran 2007

This preliminary study was conducted to discriminate the prevalence of acanthamoeba antibodiesin rheumatoid arthritis (ra) patients and healthy controls to analyze the correlation between thesetwo groups.methods: from october 2006 to august 2007 a total of 121 serum samples from ra patients attendingthe rheumatolgy department at shariati hospital in tehran were obtained and stored at -20°c until usingby indirect fluorescent-antibody test (ifat). ra was diagnosed according to the american collage ofrheumatology classification criteria. the organism used in this study was isolated from various waterresources in tehran, iran cultured axenically and then went on a pcr assay based on 18s rrna to identifythe genus acanthomoeba. indirect immunofluorescence antibody (ifa) staining of serum samples wascarried out to detect anti acanthomoeba antibodies.results: in culture, out of 22 samples, 13(59%) were grown in xenic but only two in axenic medium. pcramplified a 904bp fragment, specific for acanthamoeba. of examined serum samples, acanthamoeba antibodieswere present in 70 (57.8%) and 52 (41.2%), respectively. the highest titer of antibodies (1:320)was detected in one patient with ra.conclusion: our study supports the hypothesis that some parasitic microorganisms can involve and contributetoward the development of rheumatoid syndromes.